Stryker Corporation (0R2S.L)
| Previous Close | 331.30 |
| Open | 331.80 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 330.64 - 332.63 |
| 52 Week Range | 250.79 - 359.79 |
| Volume | |
| Avg. Volume | 6,578 |
| Market Cap | 1.23B |
| Beta (5Y Monthly) | 0.92 |
| PE Ratio (TTM) | 0.63 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Stryker declares a $0.80 per share quarterly dividend
Portage, Michigan, May 09, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable July 31, 2024 to shareholders of record at the close of business on June 28, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company off
- Business Wire
First Surgeries Using Stryker’s Infinity With Adaptis and Everlast Successfully Completed in Europe
AMSTERDAM, May 07, 2024--Stryker announced the completion of the first European surgeries using the Infinity Total Ankle System with Adaptis and Everlast technology.
- GlobeNewswire
Stryker reports first quarter 2024 operating results
Portage, Michigan, April 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2024: First Quarter Results Reported net sales increased 9.7% to $5.2 billionOrganic net sales increased 10.0%Reported operating income margin of 18.5%Adjusted operating income margin(1) increased 80 bps to 21.9%Reported EPS increased 33.1% to $2.05Adjusted EPS(1) increased 16.8% to $2.50 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant C
